Since the original discovery of T-and B-cell collaboration in the antibody response, it has been generally accepted that the helper T cell represents a single subset in the multimember family of T cells. There are, however, some controversial findings on the nature of the help with respect to its specificity, class preference, and genetic restrictions. In the antibody response to a hapten.carrier conjugate, the helper T cell is believed to recognize the carrier determinant and then to help antibody synthesis by B cells which recognize another determinant (hapten) linked to the same molecule. This type of interaction is supported by a phenomenon known as the carrier effect, in which the hapten-specific secondary antibody response is successfully elicited by the hapten coupled to the same carrier by which animals have been primarily immunized (1-4). A similar cooperative interaction between hapten-specific B cells and carrier-specific T cells is readily demonstrable in the adoptive secondary antibody response (5-8). Since in these cases hapten and carrier determinants must be present on a same single molecule, the T-B collaboration should occur upon recognition of the hapten by B cells, and recognition of the adjacent carrier determinants by T cells in a cognate form.There are certainly no denials of the presence of this type of interaction. Nevertheless, there are several examples in which the cognate interaction is not likely to occur in certain T-cell-dependent antibody responses. In fact, various antigen-nonspecific factors derived from T cells can trigger the B-cell response, in which the factors themselves do not recognize carrier determinants (9-13). Several investigators are also aware that the hapten-specific B cells can be triggered under certain circumstances in which B and T cells are independently stimulated by corresponding determinants present on two distinctly separate molecules (8,12,14,15). Hence, cognate interaction is not the only pathway for the effective T-B cell collaboration. One could ask whether the same or different helper T cells are involved in these diverse pathways of T-B cell collaboration.Such problems are now even more complicated by the growing evidence suggesting that the helper T cell may recognize not only the carrier determinants, but also the products of major histocompatibility gene complex (MHC).
SUMMARY: A total of 325 pueruli of the spiny lobster Panulirus japonicus was successfully reared in the laboratory at Minami‐Iku Station of Japan Sea‐Farming Association, Shizuoka, Japan, during 1989–1997. Of these pueruli, 136 individuals metamorphosed into the first juvenile stage. The duration of the phyllosoma stage ranged from 231 to 417 days (mean 319.4 days), and it has a tendency to extend as the increase of water volume in the rearing tanks. The number of molting in the phyllosoma stage was 20–31. The body length of the last‐stage phyllosoma ranged from 27.9 to 34.2 mm and the duration of the last stage was 11–26 days. The carapace length of the puerulus stage was 6.0–8.0 mm and the duration was 9–26 days. The present data and those of previous studies suggest that the body size and the duration of phyllosoma stage in captivity are affected by environment as in the field. The duration of the puerulus stage is considered to be controlled basically by water temperature and nutritional conditions in the phyllosoma.
The thoracic cage after a lung resection is filled by the remaining lobes, the elevated diaphragm, the diminished thoracic cage, and by mediastinal shifting. The changes in the thorax after a lung resection were quantified using magnetic resonance imaging. The study group consisted of 39 patients who had undergone a lobectomy, four who had undergone a pneumonectomy, and 14 controls. The left ventricular angle, ascending aortic angle, mediastinal shift, longitudinal length of the thoracic cage, the distance between the thoracic apex and the level of the aortic valve, and diaphragmatic elevation were all measured. After a right lower lobectomy, the mediastinum shifted more rightward than after a right upper lobectomy. The diaphragm became more greatly elevated after a right upper lobectomy than after a right lower lobectomy. When a chest wall resection was added to a right upper lobectomy, the mediastinal anatomical changes decreased. After a left upper lobectomy, the degree of mediastinal shifting was greater than after a left lower lobectomy. A left upper lobectomy shifted the mediastinum at the level of the right atrium. This method is easily reproducible and was found to be effective for quantifying the changes in the thorax after a lung resection.
To explore the anatomical repositioning of the middle lobe following right upper (RU) lobectomy, we measured the lobar volumes of the lung and the branching angles of the airway, and defined their changes after RU lobectomy in a rabbit model. Groups A1 (n = 10) and A2 (n = 10) were control groups and groups B1 (n = 10) and B2 (n = 10) underwent RU lobectomy. Casting material was introduced into the airway and a heart-lung bloc was removed form the thoracic cavity in all groups. In groups A1 and B1, the volume of each lobe of the bilateral lungs was measured, while in groups A2 and B2, bronchial casts were made and the branching angles of the airway were measured. The volume ratio of the right upper lobe (RUL) to the total lung was 12.0 +/- 0.4% in group A1; however, after RU lobectomy, the volume ratio of the right middle lobe (RML) to the total lung increased from 8.7 +/- 0.6% in group A1 to 13.5 +/- 0.8% in group B1. The volume of the left lung also increased from 43.0 +/- 0.5% in group A1 to 48.8 +/- 1.1% in group B1. The angle between the truncus intermedius and the RML bronchus was significantly smaller in group B2, at 109.0 +/- 3.5 degrees, than in group A2, in which it was 138.5 +/- 1.7 degrees. The angle between the RML bronchus and the coronal plane was 57.5 +/- 2.5 degrees in group A2 and 33.5 +/- 3.3 degrees in group B2. Our method of measuring the bronchial branching angle subsequent to RU lobectomy proved useful to illustrate postoperative positional changes and expansion of the remaining lobes.
Tumors with a maximum dimension of 3 cm are categorized as T1, whereas those greater than 3 cm are T2 by TNM classification. Some physicians suggest that early-stage peripheral lung cancer should have a maximum tumor diameter of 2 cm and that limited surgery (segmentectomy without lymph node dissection) is acceptable for the patients. In this study, the relationship between the tumor dimension and prognosis was analyzed in 207 patients with surgically treated primary non-small-cell lung cancer (SCLC). The 5-year survival rate of those with tumors 3 cm or less and without lymph node (LN) metastases was 86%, which was significantly higher than that of those with tumors more than 3 cm and without hilar and mediastinal LN metastases (65%) (p < 0.05). However, 33% of the patients with tumors 3 cm or less had LN metastases, and the 5-year survival rate did not differ between those with tumors 3 cm or less (60%) and those with tumors more than 3 cm (54%). Twenty-eight percent of patients with tumors 2 cm or less had LN metastases, and the 5-year survival rate of the patients with tumors 2 cm or less was 62%. The 5-year survival rate of those with tumors 2 cm or less and without LN metastases was 88%. Forty-six patients with tumors 2 cm or less included 5 cases with an intrapulmonary metastasis in the same lobe (11%). In conclusion, a size of 3 cm is an appropriate boundary as the T factor. Because those with tumors 2 cm or less have a relatively high percentage of LN metastases, intraoperative frozen sections of LN should be considered for those undergoing limited surgery for primary non-SCLCs 2 cm or less. Intrapulmonary metastases also should be considered for those undergoing limited surgery even if the maximum dimension of the primary tumor is less than 2 cm.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.